MicroRNA-196-5p targets Derlin-1 to induce autophagy in human osteosarcoma cells

Zhenzhong Ji1, Wei Chen2, Song Wan2

  • 1Department of Orthopedics, Wuhan Puren Hospital, Puren Hospital Affiliated of Wuhan University of Science and Technology, Wuhan, Hubei, 430080, Chinam.

Insights

MicroRNA-196-5p (miR-196-5p) suppresses osteosarcoma growth and metastasis by inducing autophagy and targeting Derlin-1. This finding offers new insights into osteosarcoma treatment and prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is a common bone cancer in children and adolescents.
  • MicroRNA (miRNA) dysregulation is implicated in osteosarcoma development.
  • The specific role of miR-196-5p in osteosarcoma requires further elucidation.

Purpose of the Study:

  • To investigate the function of miR-196-5p in human osteosarcoma cells.
  • To explore the underlying molecular mechanisms, including its effect on cell viability, autophagy, and metastasis.
  • To identify potential molecular targets of miR-196-5p in osteosarcoma.

Main Methods:

  • RT-qPCR to assess miR-196-5p expression levels.
  • Transient overexpression of miR-196-5p in osteosarcoma cell lines.
  • Western blot analysis to evaluate autophagy marker proteins (Beclin 1, LC3B II, p62, LC3BI).
  • In-silico analysis and dual-luciferase reporter assays to validate the interaction between miR-196-5p and Derlin-1.

Main Results:

  • Osteosarcoma cells showed significantly reduced miR-196-5p expression.
  • Overexpression of miR-196-5p led to decreased cell viability and colony formation by inducing autophagy.
  • miR-196-5p overexpression significantly reduced cell migration and invasion.
  • Derlin-1 was identified as a direct target of miR-196-5p in osteosarcoma cells.

Conclusions:

  • miR-196-5p plays a crucial role in suppressing osteosarcoma cell growth and metastasis.
  • The miR-196-5p/Derlin-1 axis is a key regulatory pathway in osteosarcoma.
  • Targeting miR-196-5p or its downstream effectors may offer therapeutic strategies for osteosarcoma.